The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2005) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Lu, Q. L., Rabinowitz, A., Chen, Y. C., Yokota, T., Yin, H., Alter, J., Jadoon, A., Bou-Gharios, G., & Partridge, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406700102 · Cited by 402
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
Lu, Q. L., Mann, C. J., Lou, F., Bou-Gharios, G., Morris, G. E., Xue, S.-A., Fletcher, S., Partridge, T. A., & Wilton, S. D. (2003) · Nature Medicine · doi:10.1038/nm897 · Cited by 398
Gene Therapy Progress and Prospects: Electroporation and other physical methods
Wells, D. J. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302337 · Cited by 372
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501753102 · Cited by 355
Intracellular trafficking of nonviral vectors
Medina-Kauwe, L. K., Xie, J., & Hamm-Alvarez, S. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302592 · Cited by 346
Intracellular routing of plasmid DNA during non-viral gene transfer
LECHARDEUR, D., VERKMAN, A., & LUKACS, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.008 · Cited by 340
Nuclear entry of nonviral vectors
Dean, D. A., Strong, D. D., & Zimmer, W. E. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302534 · Cited by 331
Zhang, Y., Zhang, Y.-F., Bryant, J., Charles, A., Boado, R. J., & Pardridge, W. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0740 · Cited by 330
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 321
Ogris, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00230-x · Cited by 286
Aptamer:Toxin Conjugates that Specifically Target Prostate Tumor Cells
Chu, T. C., Marks, J. W., Lavery, L. A., Faulkner, S., Rosenblum, M. G., Ellington, A. D., & Levy, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4583 · Cited by 284
Judge, A., McClintock, K., Phelps, J. R., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280
Geisbert, T. W., Hensley, L. E., Kagan, E., Yu, E. Z., Geisbert, J. B., Daddario‐DiCaprio, K., Fritz, E. A., Jahrling, P. B., McClintock, K., Phelps, J. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/504267 · Cited by 254
Kaul, G., & Amiji, M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4590-3 · Cited by 204
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & HUANG, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 195
Self-citationAptamers against extracellular targets for in vivo applications
Pestourie, C., Tavitian, B., & Duconge, F. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.013 · Cited by 183
Kaul, G., & Amiji, M. M. (2004) · Journal of drug targeting · doi:10.1080/10611860400013451 · Cited by 159
Tumor-Targeting Nanoimmunoliposome Complex for Short Interfering RNA Delivery
Pirollo, K. F., Zon, G., Rait, A. S., Zhou, Q., Yu, W. H., Hogrefe, R. I., & Chang, E. H. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.117 · Cited by 147
Synchronous selection of homing peptides for multiple tissues byin vivophage display
Kolonin, M. G., Sun, J. D., Do, K.-A., Vidal, C. I., Ji, Y., Baggerly, K., Pasqualini, R., Amp, W., Kolonin, M. G., Sun, J. D., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5186fje · Cited by 124
Engineering Synthetic Vectors for Improved DNA Delivery: Insights from Intracellular Pathways
Roth, C. M., & Sundaram, S. (2004) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.6.040803.140203 · Cited by 100
A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
Yu, W. H., Pirollo, K. F., Rait, A. S., Yu, B., Xiang, L., Huang, W.-Q., Zhou, Q., Ertem, G., & Chang, E. H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302304 · Cited by 86
Non‐immunostimulatory nonviral vectors
Liu, F., Shollenberger, L. M., & Huang, L. (2004) · The FASEB Journal · doi:10.1096/fj.04-2187fje · Cited by 70
Self-citationSellins, K. S., Fradkin, L. G., Liggitt, D., & DOW, S. W. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.008 · Cited by 64
Riu, E., Grimm, D., Huang, Z., & Kay, M. A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.558 · Cited by 49
Malley, B. W. O., Li, D., McQuone, S. J., & Ralston, R. (2005) · The Laryngoscope · doi:10.1097/00005537-200503000-00002 · Cited by 40
Cited by
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 769
Non Viral Vectors in Gene Therapy- An Overview
Ramamoorth, M. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/10443.5394 · Cited by 761
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
Daud, A. I., DeConti, R. C., Andrews, S., Urbas, P., Riker, A. I., Sondak, V. K., Munster, P. N., Sullivan, D. M., Ugen, K. E., Messina, J. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6794 · Cited by 701
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
Nitta, S., & Numata, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011629 · Cited by 666
Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing
Deleavey, G. F., & Damha, M. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.011 · Cited by 589
Metadata
- Authors
- Li, S.-D., & Huang, L.
- Venue
- Gene Therapy
- Published
- 2006-09-01
- Volume
- 13
- Issue
- 18
- Pages
- 1313-1319
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2066606615
- Cited by
- 391
- References
- 36
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.